NCT06039722View on ClinicalTrials.gov

Safety-and-effectiveness Clinical Evaluation of Nanosecond-pulse Ablation for Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

August 29, 2024

Study Completion Date

August 29, 2024

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

Pulse ablation catheter

Pulse ablation catheter is used to ablate the junction of left atrium and pulmonary vein, removing pulmonary vein potential

Trial Locations (1)

510120

the Second Affiliated Hospital of Sun Yat-sen University （Sun Yat-sen Memorial Hospital）, Guangzhou

All Listed Sponsors
lead

Shenzhen Pulsecare Medical Technology Co., Ltd.

INDUSTRY